Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Thunder Biotech
AddedFeb 15, 2024
UpdatedJun 18, 2026
Thunder Biotech

Thunder Biotech

Pre-Seed

Thunder Biotech: Innovating cancer treatment through biotechnology and immune system empowerment.

HQ
Provo, UT, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Thunder Biotech focuses on innovative cancer treatment through biotechnology. The company's core mission is to empower patients' immune systems to combat and eradicate cancer. Their approach involves modifying a patient's own immune cells, specifically macrophages, to target cancer cells more effectively.

The company's work in cancer immunotherapy represents a significant advancement in the field of oncology. By harnessing the power of the body's immune system, Thunder Biotech aims to develop more effective and potentially less toxic cancer treatments, potentially improving outcomes for cancer patients.

Thunder Biotech - Similar Companies

Umoja Biopharma logo

Umoja Biopharma

Mana Therapeutics logo

Mana Therapeutics

Immunome logo

Immunome

Taiga Biotechnologies logo

Taiga Biotechnologies

INmune Bio logo

INmune Bio

inmunebio.com

DEM Biopharma logo

DEM Biopharma

dembiopharma.com

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Modifi Bio logo

Modifi Bio

modifibio.com

Fresh Wind Biotechnologies USA logo

Fresh Wind Biotechnologies USA

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Telo Therapeutics logo

Telo Therapeutics

Sirpant Immunotherapeutics logo

Sirpant Immunotherapeutics

ImmunityBio logo

ImmunityBio

immunitybio.com

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

Thunder Biotech - Quick Facts

Who are Thunder Biotech's competitors?

Companies similar to Thunder Biotech include Umoja Biopharma, Mana Therapeutics, Immunome and Taiga Biotechnologies.

When was Thunder Biotech founded?

Thunder Biotech was founded in 2016.

Where is Thunder Biotech's headquarters located?

Thunder Biotech's headquarters is located in Provo, UT, US.

When was Thunder Biotech's last funding round?

Thunder Biotech's most recent funding round was for $1M (USD) in October 2022.

How much has Thunder Biotech raised to-date?

As of Oct 13, 2022, Thunder Biotech has raised a total of $24.4M (USD).

How many employees does Thunder Biotech have?

Thunder Biotech has 23 employees as of Feb 5, 2024.

Thunder Biotech - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified